Consistent with the previous report, TRIM44 facilitates the migration and invasion of human lung cancer cells via the NF–κB signaling pathway [14] and in another preclinical study, while TRIM44 promotes proliferation and metastasis in non–small cell lung cancer via mTOR signaling pathway [9]. Here, NFKB1 is linked to lung carcinoma.